QNRX (Quoin Pharmaceuticals, Ltd. American Depositary Shares) Stock Analysis - Analyst Ratings

Quoin Pharmaceuticals, Ltd. American Depositary Shares (QNRX) is a publicly traded Healthcare sector company. As of May 21, 2026, QNRX trades at $5.06 with a market cap of $11.11M and a P/E ratio of 0.00. QNRX moved +0.00% today. Year to date, QNRX is -64.84%; over the trailing twelve months it is -38.17%. Its 52-week range spans $4.80 to $54.95. Analyst consensus is strong buy with an average price target of $35.00. Rallies surfaces QNRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate QNRX?

3 analysts cover QNRX: 0 strong buy, 3 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $35.00.

QNRX Key Metrics

Key financial metrics for QNRX
MetricValue
Price$5.06
Market Cap$11.11M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$54.95
52-Week Low$4.80
Volume10
Avg Volume0
Revenue (TTM)$0
Net Income$-15.80M
Gross Margin0.00%

QNRX Analyst Consensus

3 analysts cover QNRX: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $35.00.

Latest QNRX News

Recent QNRX Insider Trades

  • LANGER DENNIS bought 15.15K (~$128.64K) on Oct 14, 2025.
  • Carter Denise P. bought 555.56K (~$250.00K) on Dec 23, 2024.
  • Myers Michael bought 555.56K (~$250.00K) on Dec 23, 2024.

Common questions about QNRX

What do analysts rate QNRX?
3 analysts cover QNRX: 0 strong buy, 3 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $35.00.
Does Rallies show QNRX price targets?
Yes. Rallies tracks QNRX analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is QNRX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for QNRX. It does not provide personalized investment advice.
QNRX

QNRX